Malcolm K Brenner, M.D., Ph.D.

Holland-Frei Cancer Medicine, 10th Edition

Abintus Bio Abintus Bio

BFW AAO-HNS Bulletin

Marker Therapeutics, Inc. Announces New Executive Appointments

About Us - Allogene

Malcolm Brenner, MD, PhD

Mary Ann Liebert, Inc., publishers

CD5 CAR T-Cells for Treatment of Patients with Relapsed/Refractory CD5 Expressing T-Cell Lymphoma Demonstrates Safety and Anti-Tumor Activity - Biology of Blood and Marrow Transplantation

Dr. Malcolm Brenner, MD, Oncology, Houston, TX